1. G354(P) Experience of using anti-TNF infliximab in paediatric inflammatory bowel disease- single tertiary. (25th October 2020) Authors: Hapuarachchi, DS; Belsha, D; Jagos, L; Fagbemi, A; Kadir, A Journal: Archives of disease in childhood Issue: Volume 105(2020)Supplement 1 Page Start: A126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Potency and stability of C terminal truncated human epidermal growth factor. Issue 5 (1st November 2000) Authors: Calnan, D P; Fagbemi, A; Berlanga-Acosta, J; Marchbank, T; Sizer, T; Lakhoo, K; Edwards, A D; Playford, R J Journal: Gut Issue: Volume 47:Issue 5(2000) Page Start: 622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Probiotics for maintenance of remission in ulcerative colitis. (29th September 2015) Authors: Naidoo, K; Gordon, M; Fagbemi, A; Thomas, A; Akobeng, A Journal: Archives of disease in childhood Issue: Volume 95:Supplement 1(2010) Page Start: A55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗